Cargando…
Is gemcitabine (GEM)-based combination therapy good for the treatment of advanced pancreatic cancer?
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
AME Publishing Company
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10007943/ https://www.ncbi.nlm.nih.gov/pubmed/36915424 http://dx.doi.org/10.21037/jgo-22-1090 |
| _version_ | 1784905644014305280 |
|---|---|
| author | Hao, Fulong Chen, Xinyang Li, Hancong Feng, Qingbo Hou, Yong |
| author_facet | Hao, Fulong Chen, Xinyang Li, Hancong Feng, Qingbo Hou, Yong |
| author_sort | Hao, Fulong |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10007943 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | AME Publishing Company |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-100079432023-03-12 Is gemcitabine (GEM)-based combination therapy good for the treatment of advanced pancreatic cancer? Hao, Fulong Chen, Xinyang Li, Hancong Feng, Qingbo Hou, Yong J Gastrointest Oncol Letter to the Editor AME Publishing Company 2023-01-06 2023-02-28 /pmc/articles/PMC10007943/ /pubmed/36915424 http://dx.doi.org/10.21037/jgo-22-1090 Text en 2023 Journal of Gastrointestinal Oncology. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) . |
| spellingShingle | Letter to the Editor Hao, Fulong Chen, Xinyang Li, Hancong Feng, Qingbo Hou, Yong Is gemcitabine (GEM)-based combination therapy good for the treatment of advanced pancreatic cancer? |
| title | Is gemcitabine (GEM)-based combination therapy good for the treatment of advanced pancreatic cancer? |
| title_full | Is gemcitabine (GEM)-based combination therapy good for the treatment of advanced pancreatic cancer? |
| title_fullStr | Is gemcitabine (GEM)-based combination therapy good for the treatment of advanced pancreatic cancer? |
| title_full_unstemmed | Is gemcitabine (GEM)-based combination therapy good for the treatment of advanced pancreatic cancer? |
| title_short | Is gemcitabine (GEM)-based combination therapy good for the treatment of advanced pancreatic cancer? |
| title_sort | is gemcitabine (gem)-based combination therapy good for the treatment of advanced pancreatic cancer? |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10007943/ https://www.ncbi.nlm.nih.gov/pubmed/36915424 http://dx.doi.org/10.21037/jgo-22-1090 |
| work_keys_str_mv | AT haofulong isgemcitabinegembasedcombinationtherapygoodforthetreatmentofadvancedpancreaticcancer AT chenxinyang isgemcitabinegembasedcombinationtherapygoodforthetreatmentofadvancedpancreaticcancer AT lihancong isgemcitabinegembasedcombinationtherapygoodforthetreatmentofadvancedpancreaticcancer AT fengqingbo isgemcitabinegembasedcombinationtherapygoodforthetreatmentofadvancedpancreaticcancer AT houyong isgemcitabinegembasedcombinationtherapygoodforthetreatmentofadvancedpancreaticcancer |